EU GMP Annex I Proposal Would Maintain PUPSIT, Relax WFI Restrictions

The pharmaceutical industry would lose bid to eliminate PUPSIT but win relaxed WFI in proposed EU GMP Annex I revision.

Bosch: Capping machine with highly an isolator is a hermetically sealed system with a complete separation of operator and process area © Bosch Packaging Technology
EU's GMP Annex I Revision For Sterile Drugs Maintains PUPSIT • Source: Shutterstock

The European Commission on 20 February launched a targeted consultation on a second proposed revision of the EU good manufacturing practice guideline’s Annex I for sterile drug products, last revised in 2009.

The Pharmaceutical Inspection Cooperation Scheme (PIC/S) simultaneously announced an identical consultation for member pharmaceutical inspectorates, which span the globe, to...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Manufacturing

More from Compliance